“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”
“I’ve worked with the RNA team on a number of valuation matters, large and small. These guys know their stuff. Whether using them to assist with large licensing transaction negotiations to simple tax and financial reporting work, they understand and they deliver.”
“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”
Why Biotech Executives and Investors Should Understand the... [read more]
Data-Driven Narrative for Capital Formation in Life Sciences... [read more]
Since 2015, RNA Advisors has provided valuation, transactional... [read more]
RNA Advisors, LLC, a leading valuation and strategic... [read more]
THE SITUATION: A healthcare company with a portfolio... [read more]
The Situation: Adoption of ASC 842 – Lease... [read more]
THE SITUATION: A medical device company was preparing... [read more]
THE PROBLEM: A healthcare technology company that sells... [read more]
THE PROBLEM: A publicly traded clinical stage biotech... [read more]
Enter your email address below to receive updates from RNA Advisors.
